InsidersTradesSigma
Cochlear Limited Stock: price and management transactions · Australia · ASX
Follow the Cochlear Limited stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on AU AU, under the oversight of ASX. Operating in the Health Care sector, Cochlear Limited has recorded 4 reports. Market capitalisation: €7.7bn. The latest transaction was filed on 28 April 2026 (Cease Substantial Holding). Among the most active insiders: AustralianSuper Pty Ltd. The full history is free.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cochlear Limited Buy (bullish), based on 15 analysts. Average price target: A$124.40.
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,968 of 25,936 companies
67.4
score / 100
Value51
Quality84
FCF yld1.7%
Earn yld4.8%
EV/EBITDA13.5x
ROE18%
Gross mgn74%
Net mgn17%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 April 2026
Declarations4 total
ShareASXASX:2924-03083504-2A1668630
ShareASXASX:2924-03083287-2A1668564
ShareASXASX:2924-03082752-2A1668372
ShareASXASX:2924-03081332-2A1667727
4 of 4 declarations